Kolon Life Science Inc.

KOSDAQ:A102940 Voorraadrapport

Marktkapitalisatie: ₩226.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Kolon Life Science Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Sun Jin Kim

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO1.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

Mar 12
We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Jan 18
A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

Nov 26
Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

CEO

Sun Jin Kim (63 yo)

1.5yrs

Tenure

Mr. Sun Jin Kim, M.D, Ph D, is Chief Executive Officer at Kolon Life Science Inc. since April 2023 and serves as its Director. He has been the Chief Medical Officer at Kolon TissueGene, Inc. since June 202...